Роль нарушения клеточно-матриксных взаимодействий в патогенезе прогрессирования фиброза легких
https://doi.org/10.18499/2225-7357-2016-5-3-84-89
Аннотация
Об авторах
Андрей Витальевич ХоринкоРоссия
Дмитрий Георгиевич Амарантов
Россия
Полина Владимировна Косарева
Россия
Список литературы
1. Итмезех А. Механизмы развития пневмопатии при различных путях проникновения эндотоксинов в легочную ткань / А. Итмезех, Ю.В. Дегтярь // Бюллетень Волгоградского научного центра РАМН. 2005. № 1. С. 34-35.
2. Datta A. Novel therapeutic approaches for pulmonary fibrosis Pulmonary fibrosis British Journal of Pharmacology / A. Datta, C.J. Scotton, R.C. Chambers // Themed Issue: Respiratory Pharmacology. 2011. V. 163. P. 141-172.
3. Maher T. M. Pirfenidone in idiopathic pulmonary fibrosis / T.M. Maher // Drugs Today (Barc). 2010. Vol. 46. P. 473-482.
4. Survival of Apligraf in acute human wounds / M. Griffiths [et al]. // Tissue Eng. 2004. Vol. 10. No 7-8. P. 1180-1195.
5. Scotton C. J. Molecular targets in pulmonary fibrosis: the myofibroblast in focus / C.J. Scotton, R.C. Chambers // Chest. 2007. Vol. 132. P. 1311-1321.
6. Moodley Y. P. Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis / Y.P. Moodley, P. Caterina, A.K. Scaffidi // J. Pathol. 2004. Vol. 202. P. 486-495.
7. Covering by a flap induces apoptosis of granulation tissue myofibroblasts and vascular cells / S. Garbin [et al.] // Wound Repair Regen. 1996. Vol. 4. No 2. P. 244-251.
8. Tuong V. Markers of cell proliferation, apoptosis and angiogenesis in Remodeling of bronchoalveolar duct junctions. Polish Histochemichal et Cytological Society / V. Tuong, S. Demoura, E. Kogan // Folia Histochemica et Cytobiologica. 2008. V. 46, N 2. P. 62.
9. Demoura S. Apoptosis, cell proliferation and angiogenesis in progression of different variants of idiopathic interstitial pneumonia / S. Demoura, V. Tuong, E. Kogan // European Respiratory journal. 2007. Vol. 30. No 51. P. 3405.
10. Kogan E. Initiating morphological and molecular events at bronchoalveolar duct junctions in progression of idiopathic pulmonary fibrosis / E. Kogan, V. Tuong, S. Demoura // Histopathology. 2008. Vol. 53. No 1. P. 350-351.
11. Moodley Y. P. Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/ gp130-mediated cell signaling and proliferation / Y.P. Moodley, A.K. Scaffidi, N.L. // Misso Am J Pathol. 2003. Vol. 163. P. 345-354.
12. Scotton C. J. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury / C.J. Scotton, M.A. Krupiczojc, M.J. Konigshoff // Clin Invest. 2009. Vol. 119. P. 2550-2563.
13. Moustakas A. TGFβ and matrix-regulated epithelial to mesenchymal transition / A. Moustakas, P. Heldin // Biochimica et Biophysica Acta (BBA) - General Subjects. 2014. Vol. 1840. No 8. P. 2621-2634.
14. Кузник Б. И. Клеточные и молекулярные механизмы регуляции системы гемостаза в норме и патологии / Б.И. Кузник. Чита: Экспресс-издательство, 2010. 832 c.
15. Кетлинский С. А. Цитокины / С.А. Кетлинский, А.С. Симбирцев. СПб.: Фолиант, 2008. 552 c.
16. Subramanian S. V. Induction of vascular smooth muscle alpha-actin gene transcription in transforming growth factor beta1-activated myofibroblasts mediated by dynamic interplay between the Pur repressor proteins and Sp1/Smad coactivators / S.V. Subramanian, J.A. Polikandriotis, R.J. Kelm // Mol Biol Cell. 2004. Vol. 15. P. 4532-4543.
17. Leask A. Signaling in fibrosis: targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma / A. Leask. Front Biosci (Elite Ed). 2009. Vol. 1. P. 115-122.
18. Kogan E. Matrix metalloproteinases and their tissue inhibitors in Remodeling of bronchoalveolar duct junctions / E. Kogan, V. Tuong, S. Demoura // Polish Histochemichal et Cytological Society. Folia Histochemica et Cytobiologica. 2008. Vol. 46. No 2. P. 98: P3.44.
19. Kogan E. MMPs and TIMP-4 in remodeling of extracellular matrix, fibrosis, cell proliferation in different variants of idiopathic chronic interstitial pneumonias / E. Kogan, V. Тuong, S. Demoura // Virchows archive. 2007. Vol. 451. No 2. P. 21-25.
20. Kolodsick J. E. Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts / J.E. Kolodsick, G.B. Toews, C. Jakubzick // J. Immunol. 2004. Vol. 172. P. 4068-4076.
21. Xaubet A. Cyclooxygenase-2 is up-regulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis / A. Xaubet, J. Roca-Ferrer, L. Pujols // Sarcoidosis Vasc. Diffuse Lung Dis. 2004. Vol. 21. P. 35-42.
22. Bauman K. A. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice / K.A. Bauman, S.H. Wettlaufer, K. Okunishi // J. Clin Invest. 2010. Vol. 120. P. 1950-1960.
23. Epithelial-mesenchymal transitions in development and disease / J.P. Thiery, H. Acloque, R.Y. Huang, M.A. Nieto // Cell. 2009. Vol. 139. No 5. P. 871-890.
24. Kim K. K. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis / K.K. Kim, Y. Wei, C. Szekeres // J. Clin. Invest. 2009. Vol. 119. P. 213-224.
25. Котенко К. Эпителиально-мезенхимальный переход и опухолевая прогрессия / К. Котенко // Онкология. Огляд. 2014: ZU_2014_Onko_3.qxd 27.06.2014 15:45; 39; http://health-ua.com/pics/pdf/ZU_2014_Onko_3/39.pdf.
26. Волков К. С. Роль эпителиально-мезенхимального перехода в патогенезе заживления кожных ран / К.С. Волков, С.Б. Крамар // Morphologia (Морфологiя). 2015. Т. 9. № 2. С. 7-10.
27. Wynn T. A. Cellular and molecular mechanisms of fibrosis / T.A.Wynn // The Journal of Pathology. 2008. Vol. 214. No 2. P. 199-210.
28. Осинский С. П. Микроокружение опухолевых клеток и опухолевая прогрессия. Факторы стромального микроокружения / С.П. Осинский // Здоров’я УкраÏни. 2013. № 6. С. 36-39.
29. Gunther A. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits / A. Gunther, N. Lubke, M. Ermert // Am. J. Respir. Crit. Care Med. 2003. Vol.168. P. 1358-1365.
30. Epithelial-Mesenchymal Transition in tumor microenvironment / Y. Jing [et al.] // Cell Biosci. 2011. Vol. 1. P. 29.
31. Lindsey S. Crosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition / S. Lindsey, S.A. Langhans // Front. Oncol. 2014. Vol. 4. P. 358.
32. Lamouille S. Molecular mechanisms of epithelial-mesenchymal transition / S. Lamouille, J. Xu, R. Derynck // Nat. Rev. Mol. Cell. Biol. 2014. Vol. 15. No 3. P. 178-196.
33. Yang J. Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis / J. Yang, R.A. Weinberg // Developmental Cell. 2008. Vol. 14. No 6. P. 818-829.
34. Royer C. Epithelial cell polarity: a major gatekeeper against cancer? / C. Royer, X. Lu // Cell Death Differ. 2011. Vol. 18. No 9. P. 1470-1477.
35. Xu J. TGF-induced epithelial to mesenchymal transition / J. Xu, S. Lamouille, R. Derynck // Cell Research. 2009. Vol. 19. P. 156-172.
36. Acquisition of Epithelial-Mesenchymal Transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of Notch signaling pathway / Z. Wang, Y. Li, D. Kong, S. Banerjee // Cancer Res. 2009. Vol. 69. No 6. P. 2400-2407.
37. Nieto M. A. Epithelial-Mesenchimal transition in development and desease: old views and new perspectives / M.A. Nieto // Int. J. Dev. Biol. 2008. Vol. 52. P. 1-7.
38. Heng D. Y. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study / D.Y. Heng, W. Xie, M.M. Regan // J. Clin. Oncol. 2009. Vol. 27. P. 5794-5799.
39. Кудряшов А. Г. Морфологические особенности эпителиально-мезенхимальной трансформации в карциномах почки и их связь с клиническим течением опухоли / А.Г. Кудряшов, И.В. Василенко, А.С. Малашкевич // Український Журнал Хірургії. 2011. Т. 6. №15. С. 147-154.
40. Moore B. B. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis / B.B. Moore, L. Murray, A. Das // Am. J. Respir. Cell. Mol. Biol. 2006. Vol. 35. P. 175-181.
41. Mehrad B. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis / B. Mehrad, M.D. Burdick, R.M. Strieter // Int. J. Biochem. Cell. Biol. 2009. Vol. 41. P. 1708-1718.
42. Hashimoto N. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis / N. Hashimoto, S.H. Phan, K. Imaizumi // Am. J. Respir. Cell. Mol. Biol. 2010. Vol. 43. P. 161-172.
43. Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing / N.S. Greaves, K.J. Ashcroft, M. Baguneid, A. Bayat // J. Dermatol. Sci. 2013. Vol. 72. No 3. P. 206-217.
44. Novikov N. Y. Pathomorphological changes acute lung injury / N.Y. Novikov, S.I. Dolomatov, T.I. Prokopenko // J. Health Sci. 2011. Vol. 1. No 4. P. 173-178.
45. Molecular Mediators of Angiogenesis / A.A. Ucuzian, A.A. Gassman, A.T. East, H.P. Greisler // J. Burn. Care Res. 2010. Vol. 31. No 1. P. 158.
46. Chow K. Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling / K. Chow, J.P. Fessel, E.P. Schmidt // Pulmonary Circulation. 2013. Vol. 3. No 1. P. 31-50.
47. Scotton C. J. Pulmonary fibrosis British Journal of Pharmacology / C.J. Scotton, R.C. Chambers // 2011. Vol. 163. P. 141-172.
Рецензия
Для цитирования:
Хоринко А.В., Амарантов Д.Г., Косарева П.В. Роль нарушения клеточно-матриксных взаимодействий в патогенезе прогрессирования фиброза легких. Журнал анатомии и гистопатологии. 2016;5(3):84-89. https://doi.org/10.18499/2225-7357-2016-5-3-84-89
For citation:
Khorinko A.V., Amarantov D.G., Kosareva P.V. The Role of the Disorders of Cell Matrix Interactions in the Pathogenesis of Pulmonary Fibrosis Progression. Journal of Anatomy and Histopathology. 2016;5(3):84-89. (In Russ.) https://doi.org/10.18499/2225-7357-2016-5-3-84-89